Clinical Trials Logo

Filter by:
NCT ID: NCT03484182 Active, not recruiting - Stroke Clinical Trials

Efficacy of an Interactive Web-Based Home Therapy Program After Stroke

STRONG
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This is an online study that involves assessment and training of arm function at home. Stroke is the leading cause of disability worldwide. Of the annual incidence of stroke (~750,000) in the USA about 60% fail to recover arm and hand use contributing to reduced quality of life for survivors and caregivers. How can therapists facilitate the rehabilitation of individuals with arm movement deficits and increase their quality of life over a long time period? It is known that principles of treatment including repetition, feedback, challenge and progression are important for producing recovery. The ability for patients to train at home and manage their own rehabilitation duration, intensity and progression, via effective self-management strategies, is vital. What is needed is an effective, easy to use, low cost system that self-motivates patients to intensively practice their therapy exercises at home while maintaining elements of repetition, feedback, challenge and progression. In this proposal the investigators intend to adapt just such a "web-based system" originally designed in the UK. The first version of the system has shown preliminary efficacy and feasibility in a small pilot study in UK. The investigators will adapt the system for use in the USA, with the assistance of consultants from the UK. The purpose of this study is to investigate the efficacy and feasibility of using a free, easy to use, interactive web-based upper extremity stroke rehab program on individuals with stroke who have been discharged from outpatient rehabilitation. The goal is to compare the home use of the web-based stroke rehab program with that of written exercises in a randomized controlled trial. The aims/objectives are to (1) adapt the existing system for use in America including adding bilateral activities and then to assess (2) motor function immediately before and after six weeks intervention and after 12 weeks follow up in order to support the efficacy of using this web-based intervention; (3) behavioral changes in motivation and self-efficacy at the same time points to understand the relationship between behavioral and motor function changes; (4) perceptions of patients and caregivers of the web-based program to understand feasibility and barriers to home use; and (5) perceptions of therapists to understand feasibility and barriers to clinic use.

NCT ID: NCT03484130 Active, not recruiting - Blood Pressure Clinical Trials

Prospective Phenotyping of Autonomous Aldosterone Secretion

Start date: June 15, 2018
Phase:
Study type: Observational

This prospective cohort study will investigate the physiology and progression of autonomous aldosterone secretion.

NCT ID: NCT03484078 Active, not recruiting - Clinical trials for Cerebral Palsy, Spastic

Effect of Vibration on Muscle Properties, Physical Activity and Balance in Children With Cerebral Palsy

Start date: January 23, 2019
Phase: N/A
Study type: Interventional

The aim of the 6-month randomized controlled trial, with 6-month no treatment follow-up, is to examine the effects of low-magnitude vibration on muscle, physical activity, and balance in children with spastic cerebral palsy.

NCT ID: NCT03483038 Active, not recruiting - Clinical trials for Pancreatic Adenocarcinoma

A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

Start date: December 13, 2018
Phase: Phase 2
Study type: Interventional

This is a phase II, single arm, non-randomized, open label study of liposomal irinotecan with FOLFOX in the neoadjuvant setting in patients with resectable or borderline resectable, previously untreated pancreatic adenocarcinoma. The primary objective of this study is to investigate the safety and feasibility of this treatment regimen in this patient population.

NCT ID: NCT03483012 Active, not recruiting - Breast Cancer Clinical Trials

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

Start date: May 1, 2018
Phase: Phase 2
Study type: Interventional

This research study is studying the combination of a drug called atezolizumab and a radiation procedure called stereotactic radiosurgery (SRS) as a possible treatment for triple-negative breast cancer that has spread to the brain. The interventions involved in this study are: - Atezolizumab - Stereotactic radiosurgery (SRS)

NCT ID: NCT03482791 Active, not recruiting - Esophageal Cancer Clinical Trials

Proton Beam Therapy in the Treatment of Esophageal Cancer

Start date: April 19, 2018
Phase: N/A
Study type: Interventional

The investigators plan to include both operable and inoperable patients with esophagus cancer in this prospective trial. Since both proton and photon treatments are biologically equivalent, the investigators do not expect a difference in tumor control compared to intensity modulated radiation therapy (IMRT). The investigators have a prospective experience of physician-reported toxicity and patient outcome using IMRT for patients with inoperable esophagus cancer that will serve as a comparison group. For the resectable patients receiving trimodality therapy (chemoradiation followed by surgery), the investigators will carefully track toxicity and patient outcomes prospectively. The central hypothesis is that the biologic efficacy for tumor control should be similar between protons and photons, and therefore survival measures should be similar between the two groups, but that the main difference lies in the total severe toxicities experienced by the patients undergoing therapy.

NCT ID: NCT03482557 Active, not recruiting - Breast Cancer Clinical Trials

Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening

Start date: May 17, 2018
Phase: N/A
Study type: Interventional

This research study is evaluating whether contrast enhanced mammography can be used as an alternative to breast Magnetic Resonance Imaging (MRI) for cancer screening

NCT ID: NCT03482349 Active, not recruiting - Osteoarthritis Clinical Trials

RCT Comparing Robotically-Assisted vs. Manually-Executed Total Knee Arthroplasties

Start date: March 16, 2018
Phase: N/A
Study type: Interventional

This study will explore if there are any difference in functional outcomes between two different surgical procedures for total knee replacement: robot-assisted versus manually-executed total knee arthroplasty.

NCT ID: NCT03481530 Active, not recruiting - Clinical trials for Type 2 Diabetes Mellitus

Role of CGMS Usage in Predicting Risk for Hypoglycemia

Start date: October 1, 2018
Phase:
Study type: Observational

This is a clinical study to examine rates hypoglycemia (self-report, EHR review, and review of values from a FDA approved continuous glucose monitoring system (CGMS)). Subjects will wear either blinded or unblinded CGMS. This is a 1:1 assignment with one group (50%) wearing 1 unblinded/1 blinded CGMS and the other group 50% wearing 2 blinded CGMS. The assignment will be computer based in a random fashion. Participants will continue with their usual diabetes management and glycemic monitoring profile as per usual. Those assigned to an unblinded CGMS can use the CGMS to manage their glucose levels at their own discretion. Individuals recruited will be those Type 2 diabetes who are deemed to be at high risk for hypoglycemia or low risk for hypoglycemia from a point score system established in an affiliated study.

NCT ID: NCT03481049 Active, not recruiting - Schizophrenia Clinical Trials

Individualizing Incentives for Alcohol in the Severely Mentally Ill

Start date: May 5, 2018
Phase: N/A
Study type: Interventional

The investigators will evaluate the efficacy of a 2 various contingency management (CM) interventions (High-Magnitude CM, Shaping CM) for treating heavy drinking among individuals with serious mental illness and alcohol dependence who are seen within the context of a community mental health center setting. Participants will be 400 adults diagnosed with serious mental illness and alcohol dependence and those who demonstrate heavy drinking during the first 4 weeks will be randomized to receive treatment conditions.